JACOBUS 100 101 (Dapsone 100 mg)
Pill imprint JACOBUS 100 101 has been identified as Dapsone 100 mg.
Dapsone is used in the treatment of dermatitis herpetiformis; pemphigoid; linear iga disease; leukocytoclastic vasculitis; leprosy (and more), and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for JACOBUS 100 101 (Dapsone 100 mg)
- 100 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Jacobus Pharmaceutical Company
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
|NDC Code||Manufacturer / Repackager|
|54569-2015||A S Medication Solutions LLC (repackager)|
|68258-9092||Dispensing Solutions Inc. (repackager)|
|54868-3801||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
Dapsone is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...